Logo image of CDTG

CDT ENVIRONMENTAL TECHNOLOGY (CDTG) Stock Fundamental Analysis

NASDAQ:CDTG - KYG2030P1072 - Common Stock

0.58 USD
-0.01 (-1.69%)
Last: 9/2/2025, 5:39:25 PM
0.58 USD
0 (0%)
After Hours: 9/2/2025, 5:39:25 PM
Fundamental Rating

3

Taking everything into account, CDTG scores 3 out of 10 in our fundamental rating. CDTG was compared to 84 industry peers in the Commercial Services & Supplies industry. There are concerns on the financial health of CDTG while its profitability can be described as average. CDTG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CDTG was profitable.
In the past year CDTG has reported a negative cash flow from operations.
CDTG Yearly Net Income VS EBIT VS OCF VS FCFCDTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

The Return On Assets of CDTG (3.27%) is better than 64.29% of its industry peers.
The Return On Equity of CDTG (7.84%) is better than 65.48% of its industry peers.
CDTG's Return On Invested Capital of 7.04% is fine compared to the rest of the industry. CDTG outperforms 60.71% of its industry peers.
CDTG had an Average Return On Invested Capital over the past 3 years of 12.17%. This is in line with the industry average of 10.65%.
The last Return On Invested Capital (7.04%) for CDTG is well below the 3 year average (12.17%), which needs to be investigated, but indicates that CDTG had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.27%
ROE 7.84%
ROIC 7.04%
ROA(3y)7.51%
ROA(5y)N/A
ROE(3y)16.76%
ROE(5y)N/A
ROIC(3y)12.17%
ROIC(5y)N/A
CDTG Yearly ROA, ROE, ROICCDTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30

1.3 Margins

With a decent Profit Margin value of 6.88%, CDTG is doing good in the industry, outperforming 73.81% of the companies in the same industry.
CDTG's Profit Margin has declined in the last couple of years.
CDTG has a better Operating Margin (9.02%) than 64.29% of its industry peers.
CDTG's Operating Margin has declined in the last couple of years.
CDTG has a Gross Margin of 37.10%. This is in the better half of the industry: CDTG outperforms 61.90% of its industry peers.
In the last couple of years the Gross Margin of CDTG has grown nicely.
Industry RankSector Rank
OM 9.02%
PM (TTM) 6.88%
GM 37.1%
OM growth 3Y-40.86%
OM growth 5YN/A
PM growth 3Y-44.63%
PM growth 5YN/A
GM growth 3Y1.57%
GM growth 5YN/A
CDTG Yearly Profit, Operating, Gross MarginsCDTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CDTG is creating value.
CDTG has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CDTG has an improved debt to assets ratio.
CDTG Yearly Shares OutstandingCDTG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
CDTG Yearly Total Debt VS Total AssetsCDTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

CDTG has an Altman-Z score of 1.49. This is a bad value and indicates that CDTG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CDTG (1.49) is worse than 66.67% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that CDTG is not too dependend on debt financing.
CDTG has a Debt to Equity ratio of 0.15. This is in the better half of the industry: CDTG outperforms 70.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.49
ROIC/WACC1.14
WACC6.19%
CDTG Yearly LT Debt VS Equity VS FCFCDTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

CDTG has a Current Ratio of 1.50. This is a normal value and indicates that CDTG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.50, CDTG is in line with its industry, outperforming 47.62% of the companies in the same industry.
A Quick Ratio of 1.50 indicates that CDTG should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.50, CDTG perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
CDTG Yearly Current Assets VS Current LiabilitesCDTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

CDTG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.11%.
Measured over the past years, CDTG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -39.42% on average per year.
CDTG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.54%.
Measured over the past years, CDTG shows a quite strong growth in Revenue. The Revenue has been growing by 8.11% on average per year.
EPS 1Y (TTM)-67.11%
EPS 3Y-39.42%
EPS 5YN/A
EPS Q2Q%-79.69%
Revenue 1Y (TTM)-14.54%
Revenue growth 3Y8.11%
Revenue growth 5YN/A
Sales Q2Q%-12.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CDTG Yearly Revenue VS EstimatesCDTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2.00, the valuation of CDTG can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of CDTG indicates a rather cheap valuation: CDTG is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.90, CDTG is valued rather cheaply.
Industry RankSector Rank
PE 2
Fwd PE N/A
CDTG Price Earnings VS Forward Price EarningsCDTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

98.81% of the companies in the same industry are more expensive than CDTG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.76
CDTG Per share dataCDTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CDTG!.
Industry RankSector Rank
Dividend Yield N/A

CDT ENVIRONMENTAL TECHNOLOGY

NASDAQ:CDTG (9/2/2025, 5:39:25 PM)

After market: 0.58 0 (0%)

0.58

-0.01 (-1.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.29%
Inst Owner Change116.18%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.15M
AnalystsN/A
Price TargetN/A
Short Float %1.54%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.19
P/tB 0.19
EV/EBITDA 1.76
EPS(TTM)0.29
EY50%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS3.45
BVpS3.03
TBVpS3.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 7.84%
ROCE 10.17%
ROIC 7.04%
ROICexc 7.06%
ROICexgc 7.07%
OM 9.02%
PM (TTM) 6.88%
GM 37.1%
FCFM N/A
ROA(3y)7.51%
ROA(5y)N/A
ROE(3y)16.76%
ROE(5y)N/A
ROIC(3y)12.17%
ROIC(5y)N/A
ROICexc(3y)12.25%
ROICexc(5y)N/A
ROICexgc(3y)12.26%
ROICexgc(5y)N/A
ROCE(3y)18.86%
ROCE(5y)N/A
ROICexcg growth 3Y-47.84%
ROICexcg growth 5YN/A
ROICexc growth 3Y-47.84%
ROICexc growth 5YN/A
OM growth 3Y-40.86%
OM growth 5YN/A
PM growth 3Y-44.63%
PM growth 5YN/A
GM growth 3Y1.57%
GM growth 5YN/A
F-Score2
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 1.36
Cap/Depr 1.13%
Cap/Sales 0.01%
Interest Coverage 27.92
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z 1.49
F-Score2
WACC6.19%
ROIC/WACC1.14
Cap/Depr(3y)8%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.13%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.11%
EPS 3Y-39.42%
EPS 5YN/A
EPS Q2Q%-79.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.54%
Revenue growth 3Y8.11%
Revenue growth 5YN/A
Sales Q2Q%-12.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.07%
EBIT growth 3Y-36.07%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.57%
OCF growth 3YN/A
OCF growth 5YN/A